Trevi Therapeutics Correlations

TRVI Stock

USD 6.47 0.14 2.12%

The correlation of Trevi Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Trevi Therapeutics Correlation With Market

Good diversification

The correlation between Trevi Therapeutics and DJI is -0.2 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Trevi Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Trevi Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For more detail on how to invest in Trevi Stock please use our How to Invest in Trevi Therapeutics guide.

Moving together with Trevi Stock

0.61	AZN	AstraZeneca PLC ADR	Pair Corr
0.82	OCX	OncoCyte Corp	Pair Corr
0.63	SNY	Sanofi ADR	Pair Corr
0.61	GILD	Gilead Sciences	Pair Corr
0.62	GOSS	Gossamer Bio	Pair Corr
0.75	NVCT	Nuvectis Pharma	Pair Corr
0.64	AMGN	Amgen Inc	Pair Corr

Moving against Trevi Stock

0.83	ZVSA	ZyVersa Therapeutics	Pair Corr
0.68	ELEV	Elevation Oncology	Pair Corr
0.66	CDIOW	Cardio Diagnostics	Pair Corr
0.63	GPCR	Structure Therapeutics	Pair Corr
0.63	KRON	Kronos Bio	Pair Corr
0.57	OCEAW	Ocean Biomedical	Pair Corr
0.52	MLTX	MoonLake Immunotherapeuti	Pair Corr
0.5	IMRX	Immuneering Corp	Pair Corr
0.48	IMMX	Immix Biopharma	Pair Corr
0.46	VINC	Vincerx Pharma Earnings Call This Week	Pair Corr
0.45	ZURA	Zura Bio Limited	Pair Corr
0.43	LYRA	Lyra Therapeutics	Pair Corr
0.4	ELVN	Enliven Therapeutics	Pair Corr
0.67	ASMB	Assembly Biosciences Earnings Call This Week	Pair Corr
0.66	PYXS	Pyxis Oncology	Pair Corr
0.62	CMND	Clearmind Medicine Common	Pair Corr
0.6	PMVP	Pmv Pharmaceuticals	Pair Corr
0.58	SCLX	Scilex Holding	Pair Corr
0.57	SONN	Sonnet Biotherapeutics	Pair Corr
0.55	CNSP	Cns Pharmaceuticals	Pair Corr
0.5	CGEM	Cullinan Oncology LLC	Pair Corr
0.48	ATNF	180 Life Sciences	Pair Corr
0.44	PHIO	Phio Pharmaceuticals Corp	Pair Corr
0.43	CELC	Celcuity LLC Earnings Call This Week	Pair Corr
0.4	RAIN	Rain Enhancement Tec	Pair Corr
0.34	CDIO	Cardio Diagnostics	Pair Corr
0.32	CRNX	Crinetics Pharmaceuticals	Pair Corr

Related Correlations Analysis

	LIFE	CUE	ANTX	BCAB	SPRO	BOLT	CHRS	GRCL	NLTX	FHTX
LIFE		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	LIFE
CUE	0.0		-0.59	-0.18	0.1	0.51	0.16	0.0	0.0	0.04	CUE
ANTX	0.0	-0.59		0.28	0.39	0.04	0.25	0.0	0.0	-0.22	ANTX
BCAB	0.0	-0.18	0.28		0.73	0.48	0.75	0.0	0.0	0.3	BCAB
SPRO	0.0	0.1	0.39	0.73		0.85	0.91	0.0	0.0	0.13	SPRO
BOLT	0.0	0.51	0.04	0.48	0.85		0.83	0.0	0.0	0.12	BOLT
CHRS	0.0	0.16	0.25	0.75	0.91	0.83		0.0	0.0	0.16	CHRS
GRCL	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	GRCL
NLTX	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	NLTX
FHTX	0.0	0.04	-0.22	0.3	0.13	0.12	0.16	0.0	0.0		FHTX
	LIFE	CUE	ANTX	BCAB	SPRO	BOLT	CHRS	GRCL	NLTX	FHTX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

CHRS	+ 0.91	SPRO
BOLT	+ 0.85	SPRO
CHRS	+ 0.83	BOLT
CHRS	+ 0.75	BCAB
SPRO	+ 0.73	BCAB
BOLT	+ 0.51	CUE

High negative correlations

ANTX	- 0.59	CUE
FHTX	- 0.22	ANTX
BCAB	- 0.18	CUE
FHTX	- 0.0	NLTX
FHTX	- 0.0	GRCL
NLTX	- 0.0	GRCL

Risk-Adjusted Indicators

There is a big difference between Trevi Stock performing well and Trevi Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Trevi Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
LIFE	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CUE	4.76	0.31	0.07	0.40	4.69	(6.32)	8.51	(8.57)	38.78
ANTX	2.37	0.11	0.05	0.12	2.47	(2.98)	5.41	(4.07)	17.09
BCAB	5.36	(1.66)	0.00	(0.89)	0.00	0.00	6.67	(11.59)	42.86
SPRO	2.59	(0.31)	0.00	(0.73)	0.00	0.00	5.13	(6.25)	21.98
BOLT	2.62	(0.22)	0.00	(1.21)	0.00	0.00	5.08	(6.45)	17.46
CHRS	3.99	(0.48)	0.00	(0.55)	0.00	0.00	8.42	(8.19)	31.16
GRCL	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NLTX	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
FHTX	3.69	(0.16)	0.00	(0.15)	0.00	0.00	9.05	(7.58)	26.22

Trevi Therapeutics Corporate Management

Farrell PharmD	Chief Officer	Profile
Christopher Galletta	Controller Officer	Profile
AFPM MD	Chief Officer	Profile
Danine Summers	Vice Affairs	Profile
Lisa Delfini	Chief Officer	Profile
Jennifer Good	CEO, CoFounder	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC